--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--------
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 18.070
- +0.210+1.18%
Close Dec 20 16:00 ET
- 17.900
- -0.170-0.94%
Post 20:01 ET
660.94MMarket Cap-9.20P/E (TTM)
19.085High17.520Low527.56KVolume17.570Open17.860Pre Close9.55MTurnover5.73%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.05P/B166.24MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM8.76%Amplitude16.550Historical Low18.094Avg Price1Lot Size
Rapport Therapeutics Key Stats
Rapport Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Rapport Therapeutics Earnings Reports
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data